NEXGEL to Present at H.C. Wainwright's Bioconnect Conference
NexGel, Inc. (NASDAQ: NXGL, NXGLW), based in Langhorne, Pa., specializes in high water-content hydrogels for healthcare and cosmetics.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
NexGel, Inc. (NASDAQ: NXGL, NXGLW), based in Langhorne, Pa., specializes in high water-content hydrogels for healthcare and cosmetics. On January 4, 2022, it announced that CEO Adam Levy will present at the virtual H.C. Wainwright Bioconnect Conference from January 10-13, 2022. Levy's presentation will be available on-demand starting January 10th at 7:00 a.m. ET. For details, attendees can register here. NexGel has developed over 200 hydrogel combinations for gentle skin applications.
Details
News Market Reaction – NXGL
The recorded move for NXGL in the trading session of this news was +1.60%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LANGHORNE, Pa., Jan. 4, 2022 /PRNewswire/ -- NexGel, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a manufacturer of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics, today announced that Adam Levy, Chief Executive Officer of NEXGEL, will participate in the H.C. Wainwright Bioconnect Conference to be held virtually on January 10-13, 2022. Mr. Levy's corporate presentation will be available on-demand starting Monday, January 10th at 7:00 a.m. ET. To attend, register here.
For more information about the H.C. Wainwright conference, please contact your H.C. Wainwright representative directly or KCSA Strategic Communications at NEXGEL@kcsa.com.
About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.
Investor Contacts:
Valter Pinto / Nick Staab
KCSA Strategic Communications
212.896.1254 / 212.896.1254
valter@kcsa.com / nstaab@kcsa.com
Media Contacts:
Raquel Cona
KCSA Strategic Communications
212.896.1204
rcona@kcsa.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/nexgel-to-present-at-hc-wainwrights-bioconnect-conference-301452894.html
SOURCE NEXGEL
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.